Clinical Trials Directory

Trials / Unknown

UnknownNCT01478776

The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics

The Impact of Omega-3 Supplementation on Acylation Stimulating Protein(ASP), Retinol-binding Protein 4 (RBP4) and Lipocalin-2 (LCN2) Gene Expression of ASP Receptor (C5L2) in WBC of Patient With Diabetes Type 2

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is the comparison between the effects of supplementation with omega-3 or placebo for 10 weeks in type 2 diabetics

Detailed description

Adipose tissue is recognized as an important endocrine organ in human. Not only it has function of storing unlimited energy but also its secretory roles is subject to intense research in recent years. Acylation stimulating protein(ASP), Retinol-binding protein 4 (RBP4) and lipocalin-2 (LCN2) are circulating adipokines elevated in diabetes. C5L2 is a G-protein-coupled receptor. activation of C5L2 by ASP, has been shown. Fatty acids may influence the expression of adipokines. Epidemiological studies showed that omega-3 reduce the development of insulin resistance and diabetes. Because fatty acids are the main component of adipose tissue, it is essential interest to clarify the biological effects of omega-3 on the expression of relevant adipokines.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTomega-34 cap 1 gr omega-3 per day for 10 weeks
DIETARY_SUPPLEMENTplacebopatient with type 2 diabetes who receive 4 cap placebo/day for 10 weeks

Timeline

Start date
2011-12-01
Primary completion
2013-03-01
Completion
2013-09-01
First posted
2011-11-23
Last updated
2012-12-03

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01478776. Inclusion in this directory is not an endorsement.